Concomitant Kinase-Dead BRAF and Oncogenic KRAS Lead to an Aggressive Biologic Behavior and Tumor Lysis Syndrome: A Case Report.

Holland, Roy; Ben-Ishay, Offir; Ben-Aharon, Irit

Holland, Roy; Ben-Ishay, Offir; Ben-Aharon, Irit.

Afiliación

Holland R; Division of Oncology, Rambam Health Care Campus, Haifa, Israel.
Ben-Ishay O; Division of Surgery, Rambam Health Care Campus, Haifa, Israel.
Ben-Aharon I; Rappaport Faculty of Medicine, Technion, Haifa, Israel.

Front Oncol ; 12: 885814, 2022.

Article en En | MEDLINE | ID: mdl-35586494

Palabras clave

NGS - next generation sequencing; case report; concomitant BRAF and KRAS mutations; duodenal mucinous adenocarcinoma; tumor lysis syndrome

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Israel Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google